Cymer, Inc.
Cymer, Inc. Web Site
Back to Directory   


 
  News Releases

Cymer, Inc. (ticker: CYMI, exchange: NASDAQ Global Select Market (.O)) News Release - 29-Jan-2008

Cymer Reports Fourth Quarter and 2007 Operating Results

SAN DIEGO--(BUSINESS WIRE)--Jan. 29, 2008--Cymer, Inc. (Nasdaq: CYMI), the world's leading supplier of light sources used in semiconductor lithography, today announced operating results for the fourth quarter and year ended December 31, 2007.

    For the fourth quarter of 2007:

    --  net income totaled $21,437,000, equal to $0.67 per share
        (diluted), compared to net income of $25,411,000, equal to
        $0.65 per share (diluted) in the fourth quarter of 2006 and
        net income of $21,670,000, equal to $0.65 per share (diluted)
        in the third quarter of 2007.

    --  revenue totaled $139,922,000 compared to revenue of
        $137,441,000 in the prior year's fourth quarter, and revenue
        of $132,125,000 in the third quarter of 2007.

    For the year ended December 31, 2007:

    --  net income totaled $88,362,000 equal to $2.50 per share
        (diluted), compared to net income of $95,648,000, equal to
        $2.40 per share (diluted) for the year ended December 31,
        2006.

    --  revenue totaled $521,696,000 compared to revenue of
        $543,855,000 in the prior year.

Commenting on 2007 results, Bob Akins, Cymer's chief executive officer, said, "In 2007, we shipped a record 128 of our XL platform argon fluoride (ArF) light sources during the year, which accounted for 65 percent of system shipments, and a record number of light sources for advanced ArF immersion applications. With our advanced ArF immersion light sources accounting for such a significant percentage of shipments, our currency adjusted annual average selling price (ASP) for 2007 increased to a record $1.25 million, approximately 25 percent above last year's level. With light source pulse utilization increasing approximately 20 percent over the 2006 level, non-systems revenue grew to a record $275.2 million for the year and accounted for approximately 53 percent of 2007 total revenue. "

Turning to fourth quarter results, Akins continued, "Fourth quarter 2007 revenue grew 6 percent over the prior quarter driven by continuing strong demand for our ArF immersion light sources, and by larger than forecasted fourth quarter non-systems revenue, which reached a new quarterly record. Included in the 49 lasers we shipped to our customers in the fourth quarter, were 32 XLA Series ArF light sources, and multiple XLR 500i lasers which will be installed before mid-year in advanced, high volume immersion production applications at about the 45nm node. As a result of the ongoing strong demand for ArF lasers, our currency adjusted ASP for the fourth quarter continued in excess of $1.3 million."

The company reported gross profit on product sales of $67.2 million, yielding a 48.1 percent gross margin in the fourth quarter of 2007. "Fourth quarter gross margin came in two percentage points below the previous quarter's level, primarily due to the larger than forecasted end-of-year increase in non-systems revenue, which has a lower gross margin than light sources," Akins noted. "Annual gross margin for 2007 came in at 50 percent, the first time in our history we've achieved annual gross margin at this level. This significant accomplishment reflects the improvements in operating efficiencies we've achieved over the last several years, and the strong demand for our ArF sources," he said.

The company recorded operating income of $29.2 million, yielding a 20.9 percent operating margin in the fourth quarter of 2007. For 2007, operating income totaled $114.5 million, yielding an operating margin of 21.9 percent.

Nancy Baker, Cymer's chief financial officer, stated, "Deep ultraviolet (DUV) bookings for the fourth quarter of 2007 totaled $128.7 million, resulting in a book-to-bill ratio of 0.92. Under current slowing industry conditions, this includes orders from multiple direct customers for sources that are currently scheduled for delivery beyond the current quarter. As has been the case for the last several years, ArF continued to dominate systems orders in the fourth quarter, with 75 percent of the systems booked in the quarter, and about 90 percent of the value of systems booked in the quarter being ArF. We ended the quarter with a backlog of $99.6 million, with ArF comprising 78 percent of the units, and approximately 90 percent of the value of systems, in backlog. Fifty-five percent of the value of systems in backlog at quarter-end is attributable to ArF immersion."

Baker continued, "During the fourth quarter, we completed our stock buy-back program under the $300 million authorization our board of directors approved in April 2007. Under this program, from the second quarter through the fourth quarter of 2007, we purchased a total of approximately 7.5 million shares for $300 million. We finished 2007 with approximately $357.5 million in cash, cash equivalents and investments."

Baker concluded, "For 2007, we generated a record $142.1 million in net cash from operations and spent approximately $26.8 million on the acquisition of property, equipment and patent licenses for the year, which translated to approximately $115.3 million in free cash flow. Free cash flow is calculated as the net cash provided by operating activities less the acquisition of property, equipment and patent licenses."

Corporate Outlook

Commenting on Cymer's outlook, Akins noted, "Looking forward through 2008, concerns are obviously high that a slow-down in the US economy could have global consequences, especially on consumer purchases of electronics. This in turn is reflected in the uncertainty of capital planning and buying activities at chipmakers. However, the overall thesis of the industry embracing advanced lithography technologies - ArF immersion, double patterning, and EUV -- remains intact, driven by the needs to increase productivity and reduce manufacturing costs. It is progressively more a question of when, not if, these lithography production techniques will be used. In the memory sector, we believe the larger NAND Flash manufacturers will continue with their strategic buying plans to drive to smaller critical dimensions. DRAM pricing is still weak, driving the largest manufacturers to convert their 200mm fabs to 300mm production. Logic should remain steady. Foundries, which have been under-spending, may need to augment their leading edge capabilities with some immersion tools. But in all sectors, the smaller, less financially healthy participants will most likely delay or cut portions of their capital spending."

Akins continued, "Turning to our 2008 first quarter, over the past few weeks we have been chasing a downward moving demand target. We currently see the business with all three of our direct customers to be down in the first quarter over fourth quarter levels. This is due primarily to industry conditions resulting in push-outs from chipmakers, particularly for capacity tools, into late 2008 or even 2009, with similar effect on the build plans of our direct customers. Remember for Cymer, being one step further up the supply chain, that in addition to our business slowing as our direct customers' business slows, additionally our customers become more conservative with their laser inventory levels, which further impacts laser demand. This has led to significantly reduced - that is, a double-digit unit decrease - demand for our light sources in the first quarter. Demand for our leading edge tools will bias our product mix toward XLA and XLR Series light sources so that the ASP of light source sales should remain at or above the fourth quarter level. With DUV lithography now the predominant technology for wafer processing, we anticipate continuing growth in our non-systems revenue, as we support our customers' drive to increase their utilization rates and productivity."

Based on information available at this time, Cymer is currently providing the following guidance for the first quarter of 2008, and anticipates:

    --  Total revenue to be approximately 15 percent lower than
        revenue reported for fourth quarter 2007 due primarily to
        slowing industry conditions.

    --  Foreign currency adjusted ASP to be approximately $1.35
        million on the strength of XLA and XLR demand.

    --  Gross margin to be approximately 47 percent to 48 percent, as
        lower margined non-systems revenue continues to become a
        larger percentage of total revenue.

    --  Research and development (R&D) expenses to be between $23
        million and $24 million as we continue to commercialize our
        EUV source and TCZ technologies.

    --  Selling, general and administrative expenses to be between $18
        million and $18.5 million.

    --  The estimated annual effective tax rate to be approximately 38
        percent. This higher tax rate is the result of the U.S.
        Congress not yet renewing the R&D tax credit.

Cymer's management will hold a conference call at 2:00 pm (PST) today, January 29, 2008, to discuss fourth quarter and 2007 operating results and provide first quarter 2008 guidance. This press release, the conference call and accompanying slides may be accessed on the investor relations page of the company's Web site at www.cymer.com.

Forward Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to statements regarding the company's expectations regarding future shipments and installations, and the statements under the caption "Corporate Outlook" above. These statements are predictions based on current information and expectations and involve a number of risks and uncertainties. In addition, statements regarding backlog and book-to-bill ratios should not be read as predictions or projections of future performance. Actual events or results may differ materially from those projected in any of such statements due to various factors, including but not limited to: delays or cancellations by customers of their orders, the performance and market acceptance of the company's new products or technologies; new and enhanced product offerings by competitors; the company's ability to meet its production and product development schedules; the demand for semiconductors in general, and, in particular, for leading-edge devices with smaller geometries; the timing of customer orders, shipments and acceptances; cyclicality in the market for semiconductor manufacturing equipment; the rate at which semiconductor manufacturers adopt new technologies and purchase and take delivery of photolithography tools from the company's customers; the company's ability to secure adequate supplies of critical components for its advanced products; the company's ability to manage its expense levels and unanticipated expenses, the unpredictability and volatility of the price of the company's common stock; the performance and conditions in the United States and world financial markets; the policies and actions of the United States and other governments; and general economic conditions. For a discussion of these and other factors which may cause our actual events or results to differ from those projected, please refer to the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

About Cymer

Cymer, Inc. is the world's leading supplier of DUV laser illumination sources, the essential light source for DUV photolithography systems. DUV lithography is a key enabling technology, which has allowed the semiconductor industry to meet the exacting specifications and manufacturing requirements for volume production of today's advanced semiconductor chips. Further information on Cymer may be obtained from the Company's SEC filings, the Internet at www.cymer.com or by contacting the company directly.

                    Free Cash Flow Reconciliation
                 For the year ended December 31, 2007
----------------------------------------------------------------------

Cash provided by operating activities                     $142,078,000
Less acquisition of property, equipment and patent
 licenses                                                 $ 26,758,000
                                                          ------------
Free cash flow                                            $115,320,000
                                                          ============
Cymer, Inc.            Three Months Ended       Twelve Months Ended
                           December 31               December 31
                        2006         2007         2006        2007
                    --------------------------------------------------
Total revenues      $137,441,000 $139,922,000 $543,855,000 521,696,000

Net income           $25,411,000  $21,437,000  $95,648,000  88,362,000
Diluted earnings
 per share                 $0.65        $0.67        $2.40       $2.50
Weighted average
 common shares
outstanding -
 diluted              40,643,000   33,623,000   41,397,000  36,784,000
CYMER, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)

                      For the three months    For the twelve months
                       ended December 31,      ended December 31,
                      ---------------------------------------------
                        2006        2007        2006        2007
REVENUES:
   Product sales      $136,404    $139,149    $536,098    $517,295
   Product sales -
    related party          901         626       7,362       3,716
   Other                   136         147         395         685
                      --------    --------    --------    --------

     Total revenues    137,441     139,922     543,855     521,696
                      --------    --------    --------    --------


COST AND EXPENSES:
   Cost of product
    sales               69,509      72,596     281,243     260,280
   Research and
    development         18,107      21,082      73,974      81,842
   Sales and marketing   7,975       6,568      30,618      26,163
   General and
    administrative      10,994      10,476      38,889      38,949
                      --------    --------    --------    --------


     Total costs and
      expenses         106,585     110,722     424,724     407,234
                      --------    --------    --------    --------


OPERATING INCOME        30,856      29,200     119,131     114,462
                      --------    --------    --------    --------


OTHER INCOME
 (EXPENSE):
   Foreign currency
    exchange gain          818          69       1,674       2,025
   Interest and other
    income               5,958       3,824      23,852      20,074
   Interest and other
    expense             (1,584)     (1,902)     (5,965)     (6,709)
                      --------    --------    --------    --------


     Total other
      income - net       5,192       1,991      19,561      15,390
                      --------    --------    --------    --------


INCOME BEFORE INCOME
 TAX PROVISION AND
 MINORITY INTEREST      36,048      31,191     138,692     129,852
                      --------    --------    --------    --------


INCOME TAX PROVISION    11,457      10,314      46,137      44,413
MINORITY INTEREST          820         560       3,093       2,923
                      --------    --------    --------    --------


NET INCOME             $25,411     $21,437     $95,648     $88,362
                      ========    ========    ========    ========


EARNINGS PER SHARE:
   Basic earnings per
    share                $0.68       $0.71       $2.53       $2.64
                      ========    ========    ========    ========

   Weighted average
    common shares
    outstanding -
    basic               37,140      30,404      37,779      33,522
                      ========    ========    ========    ========


   Diluted earnings
    per share            $0.65 (a)   $0.67 (a)   $2.40 (a)   $2.50 (a)
                      ========    ========    ========    ========

   Weighted average
    common shares
    outstanding -
    diluted             40,643 (a)  33,623 (a)  41,397 (a)  36,784 (a)
                      ========    ========    ========    ========



(a) As a result of applying the if-converted method for calculating
 diluted earnings per share for both the three month and twelve
 month periods ending December 31, 2006 and December 31, 2007,
 shares have been adjusted assuming conversion of our 3.5%
 convertible subordinated notes, and net income has been adjusted
 for an add back of related interest expense, net of tax. Shares
 have been adjusted by 2.8 million for both the three months and
 twelve months ending December 31, 2006 and net income has been
 adjusted by $967,000 and $3.7 million for the three months and
 twelve months ending December 31, 2006, respectively. Shares have
 been adjusted by 2.8 million for both the three months and twelve
 months ending December 31, 2007 and net income has been adjusted
 by $948,000 and $3.7 million for the three months and twelve
 months ending December 31, 2007 respectively.

CYMER, INC.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)


                                             December 31, December 31,
                                             -------------------------
                                                2006         2007
ASSETS

CURRENT ASSETS:
   Cash and cash equivalents                    $302,098     $305,707
   Short-term investments                        207,943       22,355
   Accounts receivable - net                     115,857       91,875
   Accounts receivable - related party               834        1,112
   Foreign currency forward exchange
    contracts                                        652            2
   Inventories                                   104,296      129,757
   Deferred income taxes                          46,943       42,147
   Prepaid expenses and other assets               7,143        8,928
                                             -----------  -----------


     Total current assets                        785,766      601,883

PROPERTY AND EQUIPMENT - NET                     112,074      116,725
LONG TERM INVESTMENTS                              8,384       29,443
DEFERRED INCOME TAXES                             12,766       19,272
GOODWILL - NET                                     8,833        8,833
INTANGIBLE ASSETS - NET                           15,880       12,951
OTHER ASSETS                                       5,391        5,045
                                             -----------  -----------


TOTAL ASSETS                                    $949,094     $794,152
                                             ===========  ===========


LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
   Accounts payable                              $18,711      $23,980
   Accounts payable - related party                4,858        4,428
   Accrued warranty and installation              29,974       24,832
   Accrued payroll and benefits                   21,707       24,406
   Accrued patents, royalties and other fees       4,262        3,303
   Income taxes payable                           13,293       13,468
   Deferred revenue                                2,544        4,974
   Foreign currency forward exchange
    contracts                                          -          170
   Accrued and other current liabilities           3,715        3,917
                                             -----------  -----------


     Total current liabilities                    99,064      103,478

CONVERTIBLE SUBORDINATED NOTES                   140,722      140,722
INCOME TAXES PAYABLE                                   -       17,755
DEFERRED REVENUE                                       -        5,562
OTHER LIABILITIES                                 14,781       17,401
                                             -----------  -----------


     Total liabilities                           254,567      284,918
                                             -----------  -----------


MINORITY INTEREST                                  6,633        5,711
                                             -----------  -----------


COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
   Preferred stock - authorized 5,000,000
    shares; $.001 par value, no shares issued
    or outstanding                                     -            -
   Common stock - authorized 100,000,000
    shares; $.001 par value, issued and
    outstanding 41,774,000 and 42,339,000
    shares                                            42           42
   Additional paid-in capital                    557,082      579,711
   Treasury stock at cost (4,536,000 and
    12,049,000 common shares)                   (150,704)    (450,704)
   Accumulated other comprehensive income
    (loss)                                        (4,066)         214
   Retained earnings                             285,540      374,260
                                             -----------  -----------


     Total stockholders' equity                  687,894      503,523
                                             -----------  -----------


TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY      $949,094     $794,152
                                             ===========  ===========
CYMER, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)

                                                 For the twelve months
                                                  ended December 31,
                                                 ---------------------
                                                    2006       2007

OPERATING ACTIVITIES:
   Net income                                       $95,648   $88,362
   Adjustments to reconcile net income to net
    cash provided by operating activities:
     Depreciation and amortization                   25,127    25,523
     Non-cash stock based compensation               13,235     5,642
     Minority interest                               (3,093)   (2,923)
     Provision for deferred income taxes              8,558     3,408
     Loss on disposal or impairment of property
      and equipment                                      27       292
     Change in assets and liabilities:
       Accounts receivable - net                    (26,039)   23,982
       Accounts receivable - related party             (246)     (278)
       Foreign currency forward exchange
        contracts                                     1,264       927
       Inventories                                  (15,250)  (25,461)
       Prepaid expenses and other assets               (359)   (2,218)
       Accounts payable                               1,001     5,269
       Accounts payable - related party                (117)     (430)
       Accrued and other liabilities                  9,686      (742)
       Deferred income                                  818     7,992
       Income taxes payable                           5,541    12,733
                                                 ----------- ---------

          Net cash provided by operating
           activities                               115,801   142,078
                                                 ----------- ---------

INVESTING ACTIVITIES:
   Acquisition of property and equipment            (16,404)  (26,637)
   Purchases of investments                        (278,594)  (91,440)
   Proceeds from sold or matured investments        223,004   256,720
   Acquisition of patents                            (8,200)     (121)
   Acquisition of minority interest                  (7,024)        -
                                                 ----------- ---------

          Net cash provided by (used in)
           investing activities                     (87,218)  138,522
                                                 ----------- ---------

FINANCING ACTIVITIES:
   Proceeds from issuance of common stock           116,059    15,260
   Cash investment received from minority
    shareholder                                           -     2,000
   Excess tax benefits from stock option
    exercises                                        20,243     1,727
   Repurchase of common stock into treasury        (100,704) (300,000)
                                                 ----------- ---------

          Net cash provided by (used in)
           financing activities                      35,598  (281,013)
                                                 ----------- ---------

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND
  CASH EQUIVALENTS                                    4,172     4,022
                                                 ----------- ---------

NET INCREASE (DECREASE) IN CASH AND CASH
 EQUIVALENTS                                         68,353     3,609
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE
 YEAR                                               233,745   302,098
                                                 ----------- ---------

CASH AND CASH EQUIVALENTS AT END OF THE YEAR       $302,098  $305,707
                                                 =========== =========



SUPPLEMENTAL DISCLOSURE OF CASH FLOW
 INFORMATION:
   Interest paid                                     $5,301    $5,469
                                                 =========== =========
   Income taxes paid, net                           $12,111   $26,642
                                                 ----------- ---------

    CONTACT: Investor Relations:
             Cymer, Inc.
             Terry Slavin, Director, Corp. Communications & IR
             858-385-5232
             tslavin@cymer.com
             or
             Media:
             Formula
             Kelly Hamor, 619-234-0345
             Hamor@formulapr.com

    SOURCE: Cymer, Inc.